NCT00327093 2009-02-09Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver MetastasesHospices Civils de LyonPhase 4 Terminated31 enrolled